← Back

Module 6 · Brain-Aging Frontier

Lysosome in Neurodegeneration

Lysosomal dysfunction has emerged as a common mechanistic thread across the major neurodegenerative diseases. Neurons are especially vulnerable to lysosomal failure because they are long-lived, post-mitotic, and heavily autophagy-dependent to clear aggregation-prone cytosolic proteins. The past decade has re-framed neurodegeneration as substantially a lysosomal problem.

1. Parkinson’s Disease & the GBA Link

Parkinson’s disease is characterised by α-synuclein-containing Lewy bodies in dopaminergic neurons. Heterozygous GBA mutations (the Gaucher-disease gene) confer ~5× lifetime PD risk and ~50% of non-Ashkenazi PD patients with a strong family history. Mechanism (Mazzulli 2011; Sardi 2018):

  1. Reduced GBA activity elevates glucocerebroside in the lysosome.
  2. GlcCer templates α-synuclein fibril formation (direct biochemical interaction).
  3. α-synuclein aggregates impair lysosomal autophagy, further reducing GBA delivery and enzyme function.
  4. Positive feedback drives progressive Lewy pathology.

Therapeutic: ambroxol (a cough expectorant, binds GBA and acts as pharmacological chaperone) is in Phase II trials for GBA-PD. Venglustat (glucosylceramide synthase inhibitor) trials were halted; debate continues on optimal substrate-reduction dosing. AAV-GBA1 gene-therapy (PR001) is in PD trials. LRRK2 inhibitors (denali’s DNL151, BIIB122) target another lysosomal PD-risk gene.

2. Alzheimer’s Disease

Lysosomal dysfunction in AD is multifaceted: reduced lysosomal acidification (leading to cathepsin inactivation and amyloid aggregation), altered autophagy clearance of tau and Aβ, and age-related decline in CMA. The most prominent AD-risk variant outside APP/PSEN genes is APOEε4, which impairs lipid transport and autophagy. Microglial TREM2 variants disrupt lysosomal handling of cell debris in the aging brain. PGRN loss-of-function causes neuronal ceroid lipofuscinosis + FTD via lysosomal dysfunction.

3. ALS/FTD and C9ORF72

The GGGGCC hexanucleotide repeat expansion in C9ORF72 is the most common genetic cause of ALS and frontotemporal dementia. C9ORF72 protein forms a complex with SMCR8 and WDR41 that acts as a Rab8a/Rab39b GEF on lysosomes and regulates autophagy initiation. Both loss-of-function (haploinsufficiency) and gain-of-function (RNA foci + dipeptide repeat proteins) mechanisms impair lysosomal biology in motor neurones.

4. Progranulin & Neuronal Ceroid Lipofuscinosis

Heterozygous GRN mutations cause ~5% of familial FTD. Progranulin is a secreted protein that is endocytosed, reaches the lysosome, and is cleaved by cathepsins into granulins critical for lysosomal hydrolase activity and lipid handling. Homozygous GRN loss produces CLN11, one of ~14 forms of neuronal ceroid lipofuscinosis (NCL)— a family of inherited lysosomal neurodegeneration characterised by autofluorescent lipofuscin accumulation in neurones. CLN2 (TPP1 enzyme replacement approved 2017, cerliponase alfa for late-infantile Batten disease) showed that CNS LSD therapy is possible. Progranulin-restoring agents for FTD-GRN are in clinical trials.

5. TFEB as a Therapeutic Master Switch

TFEB activates the CLEAR network of ~500 lysosomal/autophagic genes. TFEB activation — by genetic overexpression, by pharmacological compounds (including trehalose, flavonoids, small-molecule CLEAR activators) — clears aggregated α-synuclein, tau, and Aβ in cellular and animal models of neurodegeneration. TFEB-activating molecules (fluphenazine, digoxin repurposing) are in early-phase clinical development for PD and AD. The concept: therapeutically boost the lysosome-autophagy axis as a disease-modifier across multiple neurodegenerative diseases.

6. Course Synthesis

Seven modules traced the lysosome from its 1955 cell-fractionation discovery, through V-ATPase acidification, the pKa-engineered hydrolase arsenal, cargo delivery pathways, the > 50 lysosomal storage disorders and their emerging therapies, the mTORC1 signalling platform, and the lysosome’s central role in modern neurodegeneration. The lysosome is the single organelle that most exemplifies how 20th-century cell biology is being recast: from a static classification of compartments with fixed functions, to a dynamic picture of signalling hubs with rich regulation and deep disease relevance.

← Module 5Course Overview →